Bleichroeder LP Orchard Therapeutics PLC Transaction History

Bleichroeder LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $1.15 Million - $2.38 Million	-262,325 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$3.86 - $5.07 $47,574 - $62,487	12,325 Added 4.93%	262,325 $1.13 Million
Q3 2020 Nov 12, 2020	BUY	$4.11 - $6.45 $512,928 - $804,960	124,800 Added 99.68%	250,000 $1.03 Million
Q2 2020 Aug 12, 2020	BUY	$5.75 - $11.99 $714,477 - $1.49 Million	124,257 Added 13176.78%	125,200 $751,000
Q1 2020 May 14, 2020	SELL	$5.65 - $15.71 $702,052 - $1.95 Million	-124,257 Reduced 99.25%	943 $7,000
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $707,380 - $1.97 Million	125,200 New	125,200 $943,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

Stay updated on Bleichroeder LP with notifications on news.